Dubai, United Arab Emirates

Dubai Pharmacy College

www.dpc.edu
Dubai, United Arab Emirates

The Dubai Pharmacy College is the first pharmacy institution in the United Arab Emirates, established in 1992 by Dubai philanthropist Haji Saeed Bin Ahmed Al Lootah. In 2005, it won the Dubai Quality Appreciation Programme award for education presented by Sheikh Mohammed bin Rashid Al Maktoum, Crown Prince of Dubai. Wikipedia.

SEARCH FILTERS
Time filter
Source Type

CrowdReviews Partnered with Madridge Publishers to Announce: International Pharma Conference and Expo Pharma-2017 aims to discover advances, practical experiences and innovative ideas on issues related to pharma industry, pharmacology and pharmaceutical sciences as well as a breadth of other topics Pharma-2017 invites the contributions related to Pharma. Submit your work on these broad themes (or) any other topics related to Pharma. Abstracts of all the pharma related interest areas are accepted, but are not limited to the following conference themes. Pharma-2017 Conference Themes: · Pharma applications in Microbiology and Biotechnology · Pharmaceutical Chemistry · Biopharmaceutics and Pharmaceutics · Pharmacy Practice · Pharmacology · Drug Discovery and Development · Protein-Protein Interactions as Drug Targets · Pharmaceutical Nanotechnology · Drug Regulatory Affairs · Clinical Pharmacy · Pharmaceutical Technology · Pharmaceutics · Pharmacognosy and Phytochemistry For Abstract submission please see: http://pharma.madridge.com/abstract-submission.php Pharma-2017 Organizing Committee: · Bülent Gumusel, Hacettepe University, Turkey · Abubaker Ibrahim Mohamed Saeed Elbur, Taif University, Saudi Arabia. · Francesco Maione, University of Naples Federico II, Italy. · Gavin Andrews, Queens University Belfast, United kingdom. · Gian Carlo Tenore, University of Naples "Federico II," Italy. · Lisa E. Davis, University of Arizona, USA. · Majed Isa, Taif University, Saudi Arabia. · Mirza R. Baig, Dubai Pharmacy College, UAE. · Majed AIRobaian, Taif University, Saudi Arabia. · Prakash Kinthada, Sri Vidyanikethan Engineering College, India. · Tahani Alrabeni, Riyadh Colleges, Saudi Arabia. Pharma-2017 organizing an outstanding Scientific Exhibition/Program and anticipates the world’s leading specialists involved in Pharma Research. Pharma-2017 welcomes Sponsorship and Exhibitions from the Companies and Organizations who wish to showcase their products at this exciting event. Register for the conference and book your slots at: http://pharma.madridge.com/register.php Contact person: Narasimha Chary pharma@madridge.com pharma@madrodge.net Naples, FL, May 22, 2017 --( PR.com )-- International Pharma Conference and Expo is going to be held during November 20-22, 2017 at Dubai, UAE.Pharma-2017 aims to discover advances, practical experiences and innovative ideas on issues related to pharma industry, pharmacology and pharmaceutical sciences as well as a breadth of other topicsPharma-2017 invites the contributions related to Pharma. Submit your work on these broad themes (or) any other topics related to Pharma. Abstracts of all the pharma related interest areas are accepted, but are not limited to the following conference themes.Pharma-2017 Conference Themes:· Pharma applications in Microbiology and Biotechnology· Pharmaceutical Chemistry· Biopharmaceutics and Pharmaceutics· Pharmacy Practice· Pharmacology· Drug Discovery and Development· Protein-Protein Interactions as Drug Targets· Pharmaceutical Nanotechnology· Drug Regulatory Affairs· Clinical Pharmacy· Pharmaceutical Technology· Pharmaceutics· Pharmacognosy and PhytochemistryFor Abstract submission please see:Pharma-2017 Organizing Committee:· Bülent Gumusel, Hacettepe University, Turkey· Abubaker Ibrahim Mohamed Saeed Elbur, Taif University, Saudi Arabia.· Francesco Maione, University of Naples Federico II, Italy.· Gavin Andrews, Queens University Belfast, United kingdom.· Gian Carlo Tenore, University of Naples "Federico II," Italy.· Lisa E. Davis, University of Arizona, USA.· Majed Isa, Taif University, Saudi Arabia.· Mirza R. Baig, Dubai Pharmacy College, UAE.· Majed AIRobaian, Taif University, Saudi Arabia.· Prakash Kinthada, Sri Vidyanikethan Engineering College, India.· Tahani Alrabeni, Riyadh Colleges, Saudi Arabia.Pharma-2017 organizing an outstanding Scientific Exhibition/Program and anticipates the world’s leading specialists involved in Pharma Research. Pharma-2017 welcomes Sponsorship and Exhibitions from the Companies and Organizations who wish to showcase their products at this exciting event.Register for the conference and book your slots at:Contact person:Narasimha Chary


Shehab N.G.,Cairo University | Abu-Gharbieh E.,Dubai Pharmacy College
Pakistan Journal of Pharmaceutical Sciences | Year: 2012

Micromeria fruticosa L Druce subsp. serpyllifolia is a medicinal herb that is widely used as folk medicine in the treatment of abdominal pains, diarrhea, eye infections, heart disorders, elevated blood pressure, colds and wounds. This study aims to investigation the constituents and biological activity of the essential oil and aqueous extract of the plant that had been collected from Nablus. The oil was prepared by hydro-distillation method and analyzed by GC/MS. The oxygenated constituents were prevalent (87.4%) with the pulegone (58.5%) was the major constituents. Antitumor and analgesic activities of the isolated oil and the aqueous extract of M. fruticosa were investigated. Both the oil and the aqueous extract exhibited marked antitumor activities against Human Colon Tumor cells (HCT) and Mammary Carcinoma F7 (MCF7). The oil showed less IC 50s against both cell lines (10, 12.7 μg/ml respectively). Also the extract significantly inhibited acetic acid-induced writhing response (p<0.05) and increased hot-plate pain threshold of mice at doses of 100 and 200 mg/kg while the oil did not show any analgesic activity on both models. Therefore, we concluded that the aqueous extract of M. fruticosa has a remarkable inhibitory activity in non-inflammatory reactions as well as inflammatory pain.


Rasool B.K.A.,Dubai Pharmacy College | Fahmy S.A.,Helwan University
Acta Pharmaceutica | Year: 2013

The aim of the present study was to develop and characterize coated chitosan-alginate beads containing cefaclor as a controlled release delivery system. Coated cefaclor beads were prepared by solvent evaporation techniques. Beads were found to be intact and spherical in shape. Their size range was 1.05 to 2.06. The loading efficiency showed maximum value when the concentration of cefaclor, chitosan and PEG 400 was 10 % (m/V), 0.5 % (m/V) and 2 % (V/V), respectively. Best retardation of cefaclor release from chitosan-alginate beads was achieved by coating with 15 % of shellac in formula F19. A significant antimicrobial activity (p < 0.05) against Staphylococcus aureus and Klebsiella pneumoniae was observed for formula F19 compared to the standard antibiotic disc. Furthermore, the simulated plasma profile showed the superiority of F19 in sustaining drug release for more than 12 h. Therefore, shellac coated chitosan-alginate beads could be considered a successful controlled release oral cefaclor dosage form.


Shahiwala A.,Dubai Pharmacy College
Expert Opinion on Drug Delivery | Year: 2011

Introduction: Disease management of outdoor patients is mainly affected by patient compliance to the drug therapy, which in turn is governed by patient convenience. Failure to follow through with a treatment decision is one of the biggest causes of unsuccessful medical care. At present, different formulation options are available for various drugs, and hence, the decision is based on the most convenient dosage form for the patient, along with optimum therapeutic benefits. Areas covered: This paper reviews various available formulation approaches, in the hope of improving patient convenience, compliance and the overall outcome of oral drug therapy. Expert opinion: While parenterals are valued for their speed and efficiency of delivery, these systems generally score low on patient satisfaction surveys. The oral route is the preferred route for drug delivery, although it renders multiple obstacles to formulate a patient-convenient platform, such as unfavorable taste and swallowing difficulties. Transdermal drug delivery also provides high patient satisfaction, but is effective only for the delivery of smaller, lipophilic molecules. The increasing development of biopharmaceutical therapies renders an increasing number of challenges for formulation scientists to develop a more patient-convenient means of drug delivery. © 2011 Informa UK, Ltd.


Abdul Rasool B.K.,Dubai Pharmacy College | Salmo H.M.,University of Baghdad
AAPS PharmSciTech | Year: 2012

Fungal keratitis is a serious corneal disease that may result in loss of vision. There are limited treatment options available in Iraqi eye hospitals which might be the main reason behind the poor prognosis of many cases. The purpose of this study was to prepare and pharmaceutically evaluate clotrimazole-β-cyclodextrin (CTZ-β-CD) eyedrops then clinically assess its therapeutic efficacy on fungal keratitis compared with extemporaneous amphotericin B eyedrops (0.5% w/v). A CTZ-β-CD ophthalmic solution was prepared and evaluated by various physicochemical, microbiological, and biological tests. The prepared formula was stable in 0.05 M phosphate buffer pH 7.0 at 40∈±∈2°C and 75∈±∈5% RH for a period of 6 months. Light has no significant effect on the formula's stability. The CTZ-β-CD eyedrops efficiently complied with the isotonicity, sterility, and antimicrobiological preservative effectiveness tests. Results of the clinical study revealed that 20 (80%) patients showed a favorable response to the CTZ-β-CD eyedrops, while 16 patients (64%) exhibited a favorable response to amphotericin B (P∈>∈0.05). The mean course of treatment was significantly (P∈<∈0.05) less in the CTZ treatment group than in the amphotericin group (21.5∈±∈5.2 vs. 28. 3∈±∈6.4 days, respectively). The CTZ formulation was significantly (P∈<∈0.05) more effective in the management of severe cases and also against Candida sp. than amphotericin B. There was no significant difference (P∈<∈0.05) between both therapies against filamentous fungi. The CTZ-β-CD formulation can be used alternatively to other ophthalmic antimycotic treatment options in developing countries where stability, cost, or efficacy is a limiting factor. © 2012 American Association of Pharmaceutical Scientists.


Shahiwala A.,Dubai Pharmacy College
Currents in Pharmacy Teaching and Learning | Year: 2017

Background and purpose To provide pharmacy students with an opportunity to develop entrepreneurial thinking and skills. Educational activity A business proposal building project-based activity was integrated into a two-credit hour pharmacy management course during the eighth semester of the bachelor of pharmacy degree program. The student groups submitted their proposals, mimicking the process of submitting business proposals and obtaining approval in the real world. Essential management tasks including operation procedures, location and layout design, inventory management, personnel management, marketing management, and finance management were taught step-by-step so that students could work on a similar scenario with their proposal building. Students' career preferences were also measured at the beginning and end of the course. Course was assessed by written exffigam and rubric based project evaluation. Student feedbacks of the project were collected using a five-point Likert scale. Findings The project-based activity was well integrated in the course. The project helped the students (n=72) to understand management concepts more clearly, which was reflected by their significantly higher (p<0.01) grades compared to previous year. Students' feedback was overwhelmingly positive (mean score of 4.53 on the scale of 5). Students developed both interest and confidence to start a pharmacy as a result of this activity. Summary The project was successfully designed and executed in a pharmacy management course within a bachelor of pharmacy curriculum. Based on the response received in this project, efforts will be made to provide guidance and support to the students by calling field experts such as pharmacy owners and financiers. © 2017 Elsevier Inc.


Chaudhary S.A.,National Institute of Pharmaceutical Education and Research, Ahmedabad | Shahiwala A.F.,Dubai Pharmacy College
Expert Opinion on Drug Delivery | Year: 2010

Importance of the field: Over the years, patient convenience and patient compliance-orientated research in the field of drug delivery has resulted in bringing out potential innovative drug delivery options. Out of which, medicated chewing gum (MCG) offers a highly convenient patient-compliant way of dosing medications, not only for special population groups with swallowing difficulties such as children and the elderly, but also for the general population, including the young generation. Areas covered in this review: In this review, various formulation ingredients, different manufacturing processes, and assessment of in vivo and in vitro drug release from MCG are thoroughly discussed along with the therapeutic potential and limitations of MCG. What the reader will gain: Readers will gain knowledge about the rationale and prominent formulation and performance evaluation strategies behind chewing gum as a drug delivery system. Take home message: The availability of directly compressible co-processed gum material enables rapid, safe and low-cost development of MCG as a drug delivery option. By MCG formulation, revitalization of old products and reformulation of new patented products is possible, to differentiate them from upcoming generics competition in the market. © 2010 Informa UK Ltd.


Shahiwala A.,Dubai Pharmacy College
European Journal of Drug Metabolism and Pharmacokinetics | Year: 2013

Physicochemical properties, such as molecular weight, size, partition coefficient, acid dissociation constant and solubility have a great impact on pharmacokinetics of traditional small molecule drugs and substantially used in development of small drugs. However, predicting pharmacokinetic fate (absorption, distribution, metabolism and elimination) of protein therapeutics from their physicochemical parameters is extremely difficult due to the macromolecular nature of therapeutic proteins and peptides. Their structural complexity and immunogenicity are other contributing factors that determine their biological fate. Therefore, to develop generalized strategies concerning development of therapeutic proteins and peptides are highly challenging. However, reviewing the literature, authors found that physiochemical properties, such as molecular weight, charge and structural modification are having great impact on pharmacokinetics of protein therapeutics and an attempt is made to provide the major findings in this manuscript. This manuscript will serve to provide some bases for developing protein therapeutics with desired pharmacokinetic profile. © 2013 Springer-Verlag France.


Al Khalidi D.,Dubai Pharmacy College | Wazaify M.,University of Jordan
International Journal of Clinical Pharmacy | Year: 2013

Background The myriad changes in pharmacy practice in Jordan have transformed the pharmacist's role to be more focused on the patient and his/her therapeutic needs than on just the traditional dispensing. This, in addition to other possible factors, is believed to have influenced pharmacists' job satisfaction and stress level in different practice settings in Jordan. Objective This study aimed to determine the level of job satisfaction and job related stress among pharmacists in Amman. Moreover, the main causes of dissatisfaction and stress-related factors affecting pharmacists at their working positions were also explored. Setting The study was conducted in four pharmacy practice settings: independent and chain community pharmacies as well as private and public hospital pharmacies. Methods The study adopted the self-administered survey methodology technique using a pre-validated pre-piloted questionnaire. The questionnaire was adapted from one previously used in Northern Ireland. Data were entered into SAS database and analysed using descriptive statistics, Chi square and regression analysis. The significance level was set at P < 0.05. Main outcome measure The level and factors affecting job satisfaction and job related stress as reported by participating pharmacists. Results A total of 235 registered pharmacists in Amman were involved. The pharmacists' job satisfaction was significantly affected by the type of pharmacy practice settings (P = 0.038), pharmacists' registration year (P = 0.048) and marital status (P = 0.023). Moreover, job related stress situations like patient care responsibility have been associated significantly with the type of pharmacy practice settings (P = 0.043) and pharmacists' registration year (P = 0.013). Other job stressors like long working hours, lack of advancement, promotion opportunities and poor physician pharmacists' relationship have also been reported by participants. Conclusion The study concluded that community pharmacists in Amman are found to be less satisfied with their jobs than their hospital counterparts. Pharmacists' job satisfaction should be enhanced to improve pharmacists' motivation and competence. Consequently, this will improve their productivity and provision of pharmaceutical care. © 2013 Springer Science+Business Media Dordrecht.


Patil S.S.,Ranchi University | Shahiwala A.,Dubai Pharmacy College
Expert Opinion on Therapeutic Patents | Year: 2014

Introduction: Oral-controlled and modified-release drug delivery systems with zero-order sustained-release kinetics have been developed and proven suitable for meeting increasingly sophisticated therapeutic needs. Nevertheless, the impact of basic chronobiology concepts on the practice of medicine is still ongoing and to address chronotherapy needs, various types of pulsatile drug delivery systems have been innovated. The purpose of this review is to highlight these innovations in the field of chronotherapy.Areas covered: The present review discusses in depth on recent patents and developments related to pulsatile drug delivery systems with eroding, soluble or rupturable barrier coatings, and systems with capsular structures. Besides focusing on all recent innovations, the review addresses the novelty and feasibility of all upcoming technologies being exploited considering pulsatile drug delivery systems.Expert opinion: There has been a growing interest in pulsatile delivery, which generally refers to the liberation of drugs following a programmable and well-defined lag phase from the time of administration. From 1981 until the present date, patent publications related to pulsatile drug delivery have shown more promising systems with numerous developments in arena of drug delivery. Future development of chronotherapeutic medications requires proper assessment and integration with other emerging disciplines such as hydrogel and transdermal delivery systems. The selection of the appropriate chronopharmaceutical technology should take into considerations with the ease of manufacturing and the cost-effectiveness. © 2014 Informa UK, Ltd.

Loading Dubai Pharmacy College collaborators
Loading Dubai Pharmacy College collaborators